arXiv · 2109.09411
Medica-Plus: a Micromegas-based proof-of-concept detector for sub-becquerel tritium activity assessment at the service of oncological research
Abstract
To fulfill needs in oncological research a new Micromegas detector has been developed to follow radiolabelled drugs in living organisms at the single cell level. This article describes the proof-of-concept of such a detector and compares its ability to detect and assess sub-becquerel \tritium~activities with a commercial $\beta$-imager
Explore related subjects
Keep this discovery
F. Jambon, S. Aune, P. Baron, T. Benoit, T. Bey, D. Desforge, E. Ferrer-Ribas, A. Grabas, M. Kebbiri, I. Mandjavidze, T. Papaevangelou, M. Riallot, M. Vandenbroucke, F. Beau, V. Dive, C. Malgorn, F. Malloggi, A. Rousselot, F. Carrel, M. Trocmé. 2021-09-20. Medica-Plus: a Micromegas-based proof-of-concept detector for sub-becquerel tritium activity assessment at the service of oncological research. https://doi.org/10.1016/j.nima.2022.166332
Cite the original work for its findings. Save a collection to share your selection of sources.